Novo reaches share milestone, analyst credits Wegovy
Shares in Novo Nordisk have increased by more than 300% in value since 2017, far outstripping the C25 index as a whole.
by marketwire, translated by catherine brett
On Thursday, Novo Nordisk’s market value exceeded DKK 2trn (USD 283bn) for the first time ever. The company’s share price has increased by over 300% since Lars Fruergaard Jørgensen started as CEO in early 2017, while the C25 index as a whole, which includes the 25 biggest companies in Denmark, is up by 66% over the same period, Danish financial daily Børsen reports.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk moves digital unit, appoints new head
For subscribers
